March 15, 2018
Nordic Nanovector to Present Preclinical Data Highlighting the Anti-tumour Effect of Humalutin® in Three Lymphoma Models at AACR 2018
Media
March 15, 2018
Onxeo to Present Results of Two Studies Highlighting Potential of AsiDNA™ as Anti-Cancer Treatment at 2018 AACR Annual Meeting
March 15, 2018
Targovax ASA: Notice of Annual General Meeting
March 14, 2018
Onxeo Provides Financial Update
March 12, 2018
Strongbridge Biopharma plc Reports Full-Year 2017 Financial Results
March 12, 2018
Nordic Nanovector to Present at the China Healthcare Investing & Partnering Symposium in China and Stifel Nordic Healthcare Seminar in London
March 12, 2018
Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program
March 12, 2018
Wilson Therapeutics announces agenda for Capital Markets Day on 21 March 2018
March 07, 2018
Strongbridge Biopharma Investor and Analyst Day – Save the Date
March 07, 2018
Approval to launch the Phase I Study of repeated and increasing doses to assess CER-209 in NASH/NAFLD